MedTrace Logo

A Study of Oral Kavalactones Effect on Nurses

NCT06177535 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-04-23

No results posted yet for this study

Summary

This research study is being done to assess the impact of taking Kava extract (Piper methysticum), a dietary supplement on cortisol in a healthy nursing population.

Conditions

  • Stress

Interventions

DIETARY_SUPPLEMENT

Kavalactones

Three 75 mg capsules orally once daily within one hour of bedtime (225 mg total/day)

DRUG

Placebo

Three capsules orally once daily within one hour of bedtime. Looks exactly like the study drug, but it contains no active ingredient.

Sponsors & Collaborators

Principal Investigators

  • Brent Bauer, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-05
Primary Completion
2026-05-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06177535 on ClinicalTrials.gov